The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double-Blind Clinical Trial
Caroline M. Moore(University College London Hospitals NHS Foundation Trust), Mark Emberton(University College London), Giulio Gambarota(Inserm), Hashim U. Ahmed(National Health Service), Brandon Whitcher(Royal Marsden NHS Foundation Trust), Adebiyi Damola(National Health Service), Francesco Giganti(University College Hospital), Mathias Winkler(National Health Service), Simon Bott(Prostate Cancer Research), Ashley Ridout(National Health Service), Alex Freeman(University College London), Neil McCartan(University College London), Gareth Ambler(University College London), Alex Kirkham, Charles Jameson(Royal London Hospital), Manit Arya(Princess Alexandra Hospital NHS Trust), Nicola L. Robertson(University College London Hospitals NHS Foundation Trust), Ramiro Castro(GlaxoSmithKline (United States)), Fatima Jichi(Royal London Hospital), Clare Allen(St Peter's Hospital), Anita Mitra(University College Hospital)
Cited by 28
Related Papers
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
|The Lancet|2017|3.2k
A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical Hubs
|Journal of Neuroscience|2006|2.5k
An Introduction to Wavelets and Other Filtering Methods in Finance and Economics
|Elsevier eBooks|2002|1.1k
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694